Found 6 matching trials
28 Day Repeat Dose in Cystic Fibrosis Patients
PHASE2The purpose of this study is to determine whether the safety, tolerability ...
Location
GSK Investigational Site
SD Cystic Fibrosis Study
PHASE1Subject with Cystic Fibrosis have increased clearance of many drugs. Based ...
Location
GSK Investigational Site
Evaluate the Effects of the Drug (SB-656933-AAA) on the Body After a Single Dose in Subjects Who Have Inhaled Ozone
PHASE1A study to evaluate the effect of SB-656933-AAA on the body after a single ...
Location
GSK Investigational Site
Study to Evaluate the Pharmacodynamics of SB-656933 in Patients With Ulcerative Colitis
PHASE2This study will involve the use of a new compound, SB-656933. Accumulation ...
Location
GSK Investigational Site
A Study To Evaluate The Safety And Tolerability Of SB-656933-AAA Following Repeated Doses In Healthy Adult Subjects
PHASE1To assess safety of SB-656933 following repeat dosing for 14 days....
Location
GSK Investigational Site
Repeat Dose Study in Male Healthy Volunteer Smokers
PHASE1This is a 4 to 6 week study to look at the safety and PK profile of SB65693...
Location
GSK Investigational Site